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RE:

Medical Monitoring Working Group Meeting Minutes

Agency Representatives:
I’m writing to you on behalf of Atlantic Richfield Company and Butte-Silver Bow to submit the
minutes from the Medical Monitoring Working Group meeting held on October 25, 2022. The
minutes document the agenda and discussion highlights from this meeting which focused on
planning for the Phase 3 health study. The meeting minutes may be downloaded at the following
link:
https://pioneertechnicalservices.sharepoint.com/:f:/s/submitted/EtLwae2ZAhtFuglvx94LJqQBOvE2i
3iKrnFwb6pYQtyDxQ.
If you have any questions or comments, please call me at (907) 355-3914 or Eric Hassler at
(406) 497-5042.

Sincerely,

_____________________________________
Mike Mc Anulty
Liability Manager
Remediation Management Services Company
An affiliate of Atlantic Richfield Company

____________________________________
Eric Hassler, Director
Department of Reclamation
and Environmental Services
Butte-Silver Bow
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Meeting: Butte Medical Monitoring Working Group Meeting
Date/Time: October 25, 3:30 pm Mountain
Location: Atlantic Richfield’s Butte office (the Kelley) and Virtual (Teams)
Attendees:
• USEPA (via Teams) – Nikia Greene, Dr. Charlie Partridge
• USEPA Technical Consultant (via Teams) – Lynn Woodbury (CDM Smith)
• BSBHD – Karen Maloughney (Health Officer), Kayla Harvey (Environmental Nurse), Julia Crain
(RMAP), and Amanda Marinovich (Epidemiologist) (via Teams); Eric Hassler, Brandon Warner
(RMAP)
• BSB Environmental Database Consultant – David Dobrinen (Woodard & Curran)
• MDEQ (via Teams)– Daryl Reed
• AR – Mike Mc Anulty
• AR Technical Consultants – Dr. Rosalind Schoof, Amanda Bailey (Ramboll)
• MDPHHS – (via Teams) Dawn Nelson (State Toxicologist), Abbie Phillip
• BSB Health Advisory Group – Dr. Seth Cornell
• CTEC Representatives – Dr. Bill Macgregor (via Teams), Joe Griffin
Minutes drafted by: Amanda Bailey (Ramboll)
Agenda
• Introductions
• Phase 3 2018-2020 BLL data update (neighborhood and house age summaries)
• Environmental data – Work Plan / Feasibility Study questions
• Other updates since last meeting:
o Status of BLL data collection and venous confirmation sampling in 2022 (BSBHD)
o Potential Montana reference population(s) (MDPHHS)
o Implications of CDC BLRV (EPA)
• Other business, next steps, plan for next call
Introductions
Introduced Working Group (WG) members present in person and via Teams
Phase 3 2018-2020 blood lead level (BLL) data update
Presented blood lead records summary information including:
• Numbers and percentages of records by neighborhood (1-8) for children aged 60 months or less
living within the study area (834 total for 2018 through Q1 2020)
• Numbers and percentages of records for children aged 60 months or less living within each
neighborhood (1-8) with BLLs above the detection limit of 3.3 µg/dL, the current CDC blood lead
reference value (BLRV) of 3.5 µg/dL, and the Phase 1/2 reference value of 5 µg/dL
• Numbers and percentages of houses with blood lead records falling into 4 age categories: pre1940, 1940-1949, 1950-1977, post-1977

Discussion:
• Dr. Partridge wanted to know how many children live in each neighborhood and what percent
were tested
o This information may be obtained from the census, but will need to match census years
and ages of most kids when tested
• Pre-1940 lead content in paint was higher, so looking at pre-1940 homes as a separate bin is
informative
• Other bins could potentially be condensed (1940- or 1950-1977, post-1977)
• Bins are mostly to give an idea of house age differences between neighborhoods, but grouping
will not be necessary for regression analysis
• House age is tracked during RMAP assessments so this could be provided with blood lead data in
the future
o Usually we use the original build date, rather than remodel date
• Question about availability of remodel data (potential exposure source)
o Remodels are generally not well tracked because a permit is not required/obtained for
most activities
o EPA noted ICIAP covers remodeling, but this will not give complete information
• It would be helpful to know how many parcels in census tract 8 are not included in the study area
o Influx of housing west of neighborhoods 6 and 8 in the last 10 years
• Discussed adding a new “neighborhood” comprised of the expanded RMAP area where services
are now offered to include more data
o It was explained that these data would be considered separately and would not “skew”
assessment of blood lead changes over time in the existing neighborhoods
o This could include areas such as Rocker/south of Rocker, Ramsey, Fairmont, German
Gulch, Molton, White Creek Estates
o Many of these areas are also on groundwater wells rather than municipal water supply
Environmental data – Work Plan / Feasibility Study questions
Introduced potential analyses incorporating environmental data that could be included in the Phase 3
study, and initial actions to address questions related to feasibility and neighborhood/individual level
analyses
Presented the following:
• Numbers of parcels (residential and vacant lots) with soil samples, and numbers of soil samples,
by neighborhood
• Heat maps showing median parcel soil lead concentrations (with kriging), for residential parcels
and vacant lots, along with neighborhood boundaries, for:
o Phase 3 study period, before and after abatement
o Phase 1, 2, and 3 study periods, after abatement
• Comparison of data distribution among study neighborhoods for soil samples and blood lead
records
• Example template for environmental data (soil only, for now) to be pulled into blood lead
dataset

Discussion of Work Plan:
• A Work Plan will need to be submitted for review by a human subjects study institutional review
board (IRB)
• Work that combines environmental and blood lead data needs to be done by designated staff
with required training and IRB oversight because confidentiality cannot be maintained
(addresses are needed to link environmental and blood lead data)
Discussion of environmental data/heat maps:
• Clarified that no post-remediation data are available; 50 mg/kg was used as a surrogate
concentration to replace concentrations >1,200 mg/kg that triggered remedial action
• Mean, rather than median (current figures), is likely the most appropriate statistic for heat maps
to evaluate exposure at the neighborhood (rather than individual) level
• Maps based on maximum concentrations are also included in extra slides
• Schools and parks not included to start, could add eventually
o However, parks and schools have had very few actionable lead concentrations (even in
indoor dust at schools) and including them may even lower average soil concentrations
o Also, children ages 5 and under are the focus of this study, and will mostly spend time at
parks and daycares, not schools
o Data from schools, parks, and daycares should be captured at the end of the study
• All depth intervals are included in current figures; might look at surface soil (0-2 inches) only for
assessing exposure
o Only 0-2 inch soil was sampled under RMAP until 2010
o UAO required triple depth (0-2, 2-6, and 6-12 inch) sampling starting in 2012, and this
started proactively in 2010
• Blood lead and property information can’t be kept confidential if adding soil data, so dedicated
data storage and limited access (only those trained for human subjects analysis) would need to
be applied
o BSB staff have this training
o Information would be made anonymous before reporting out
o Dr. Macgregor noted his team used the nearest intersection to the property in question
to maintain confidentiality
• Indoor dust, whether sourced from soil track-in or lead paint, has been shown to have a
stronger relationship with blood lead compared to soil
• Air, diet, and water become the primary contributors when blood lead levels are lower (3.5
µg/dL or less); at 5 µg/dL soil and dust still may be significant contributors (~50%)
• Dr. Partridge observed that with most blood lead levels being less than 3.5 µg/dL, there is likely
to be a discordance between blood lead values and soil concentrations
• Analyses could be conducted on Phase 1 and 2 blood lead data for which soil data are now
available, to assess potential connection between soil lead concentrations and when blood lead
levels were higher than they are now
• Indoor dust is currently sampled only if there is a pathway from an attic to a living space, or as
part of an elevated BLL investigation
o Only ~300 indoor dust samples have been collected so far, likely not enough for a strong
analysis of blood lead/indoor dust relationship in Phase 3 study
o BSB will start collecting indoor dust samples proactively

There is a potential concern about reliance on indoor dust data due to potential
mismatches between the timing of indoor dust data collection and blood lead samples
because indoor dust concentrations may vary over time, whereas soil concentrations
are expected to be stable over time unless remediated
Clarified that blood lead sample collection is not proposed for the Phase 3 study; this study will
only use data already being collected, but this could be considered for a future study
Questionnaires administered during RMAP home evaluations include behavioral/source
questions
o This information could be used to further evaluate elevated blood lead levels, if it can be
obtained (reported annually)
Data table template – add:
o Sample depth
o Parcel component (e.g., front yard, side yard, play area)
Risk assessors also want a Lab/XRF data column and XRF paint data
o Pre-2019 soil and dust data are XRF, post-2019 data are ICP; 2019 data include both, as
the change from XRF to ICP occurred during 2019
o Lab/XRF column could be populated using a cut-off date or lab name
Paint data are limited because inspections are only done if an elevated BLL is detected, so not
likely useful for this study
Secondary addresses are only documented in hard copy files, and only for elevated BLLs
o

•
•

•
•

•
•

Other updates since last meeting
Status of EPA BLL target
• Nothing new to report
Status of BLL data collection in 2022
• WIC program is fully operational and capillary sample collection resumed late June
• Environmental nurse has been able to work with parents to facilitate confirmation sampling
when elevated capillary results occur
o Venous sample collection onsite same day or within a few days, or
o Follow-up with their primary care physician
• 126 blood lead capillary samples collected since late June
o 19 detectable at 3.3 µg/dL
o 13 venous confirmation samples taken onsite, 6 followed up with primary care physician
o Confirmation sample results are kept in same data file with capillary data so all results
are together in one database
Potential Montana reference population(s)
• Reporting requirement changed to 3.5 µg/dL on 9/24
• 75% increase in reportable results due to lower reporting threshold
Next Working Group meeting
• Discussed having next meeting on February 14, 21, or 28
o No preferences noted
o Working group members will follow up with any conflicts or preferences

